Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Classes and Categories01:25

Drug Classes and Categories

2.1K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.1K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

803
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
803
Antidotes01:17

Antidotes

710
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
710
Drug Regulation01:25

Drug Regulation

1.5K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.5K
Pharmacovigilance01:19

Pharmacovigilance

933
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
933
Hazard Ratio01:12

Hazard Ratio

187
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
187

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tackling medication errors: how a systems approach improves patient safety.

European journal of hospital pharmacy : science and practice·2025
Same author

Investigation of the hospital pharmacy profession in Europe.

European journal of hospital pharmacy : science and practice·2024
Same author

Results of EAHP's 2023 shortages survey.

European journal of hospital pharmacy : science and practice·2024
Same author

Hospital pharmacy workforce.

European journal of hospital pharmacy : science and practice·2023
Same author

Digital health.

European journal of hospital pharmacy : science and practice·2023
Same author

Infectious diseases and antimicrobial resistance.

European journal of hospital pharmacy : science and practice·2023
Same journal

The invisible workload of enteral nutrition: viscosity matters.

European journal of hospital pharmacy : science and practice·2026
Same journal

Reuse of fixed-dose monoclonal antibodies in oncology: retrospective and pharmacoeconomic analysis in a chemotherapy reconstitution unit.

European journal of hospital pharmacy : science and practice·2026
Same journal

Chemical and visual compatibility of dexmedetomidine injection with parenteral medications used in neonatal intensive care settings.

European journal of hospital pharmacy : science and practice·2026
Same journal

Use of the 'Making Medicines Work for You' screener to identify medication adherence barriers in heart failure patients.

European journal of hospital pharmacy : science and practice·2026
Same journal

Extended physicochemical stability of ready-to-administer fosnetupitant/palonosetron infusion solutions and admixtures with dexamethasone injection.

European journal of hospital pharmacy : science and practice·2026
Same journal

Chemical and visual compatibility of fluconazole injection with parenteral medications used in neonatal intensive care settings.

European journal of hospital pharmacy : science and practice·2026
See all related articles

Related Experiment Video

Updated: Aug 6, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.3K

Hazardous medicinal products

Aida Batista1, Despina Makridaki2, Tjalling van der Schors3

  • 1Pharmacy, Centro Hospitalar do Médio Ave EPE, Santo Tirso, Portugal.

European Journal of Hospital Pharmacy : Science and Practice
|March 15, 2023
PubMed
Summary

No abstract available in PubMed .

Keywords:
Education, Pharmacy, ContinuingPHARMACEUTICAL PREPARATIONSPHARMACY SERVICE, HOSPITALSafetyWorkforce

More Related Videos

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

14.3K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Related Experiment Videos

Last Updated: Aug 6, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.3K
Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
12:05

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies

Published on: March 6, 2013

14.3K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K